Abstract 4684: A RHNO1-ATR/Chk1 positive feedback loop sustains the cellular DNA replication stress response

Abstract Cancer cells are continually challenged by both intrinsic and extrinsic stresses that interfere with DNA replication, causing DNA replication stress (DRS). DRS can fuel cancer progression by increasing genomic instability, but if left unregulated, it can also cause widespread DNA damage and cell death. Consequently, cancer cells are highly dependent on the ATR/Chk1 signaling pathway to regulate DRS and ensure survival. Rad9-Hus1-Rad1 interacting nuclear orphan 1 (RHNO1) is a novel component of the ATR/Chk1 pathway and is often overexpressed in cancer cells with high DRS, where it contributes to chemotherapy resistance. However, the precise function of RHNO1 in the DRS response is still largely unknown. Here, we investigated the roles of RHNO1 in cancer progression and DRS response using an ovarian cancer cell (OVC) model in both in vitro and in vivo systems. Furthermore, we generated an endogenously HiBiT-tagged and degron-tagged RHNO1 cell line to precisely track RHNO1 levels and temporally deplete RHNO1 during different phases of the DRS response in HEK293T cells. Depletion of RHNO1 significantly reduces OVC proliferation rate, clonogenicity, and in vivo tumor growth, while extending host mouse survival. RHNO1 knockdown sensitized cells to hydroxyurea (HU), increasing cell death and micronuclei formation. Mechanistically, RHNO1 was upregulated and stabilized following DRS. Notably, we show that RHNO1 stabilization is mediated by ATR/Chk1 phosphorylation, which is also required for RHNO1 translocation to stressed replication forks. Interestingly, chromatin recruitment of RHNO1 appears to be independent of 9-1-1, a DNA clamp complex previously known to bind RHNO1. Furthermore, cells with stable RHNO1 knockdown demonstrated normal initial ATR/Chk1 signaling activation in response to HU treatment, however, at later time points, the absence of RHNO1 caused premature termination of ATR/Chk1 signaling despite the persistence of DRS. These findings are consistent with a dispensable role of RHNO1 in the initial activation of the ATR/Chk1 pathway but a key role in sustaining the ATR/Chk1 response. In summary, we demonstrated the RHNO1 promote critical OVC phenotypes and uncovered a novel positive feedback loop between RHNO1 and ATR/Chk1 signaling. This work identifies RHNO1 as a key component in maintaining the DRS response, highlighting its potential as a therapeutic target for cancers reliant on ATR/Chk1 signaling. Citation Format: Niphat Jirapongwattana, Carley M. Conover, Catalina Trujillo Jaramillo, Adam R. Karpf. A RHNO1-ATR/Chk1 positive feedback loop sustains the cellular DNA replication stress response [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 4684.

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2026-04-03
DOI
https://doi.org/10.1158/1538-7445.am2026-4684
Primary Topic
DNA Repair Mechanisms
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 4684: A RHNO1-ATR/Chk1 positive feedback loop sustains the cellular DNA replication stress response

Niphat Jirapongwattana, Adam R. Karpf, Carley Conover, Catalina Trujillo Jaramillo
Cancer Research
DNA Repair Mechanisms
article

Abstract 4684: A RHNO1-ATR/Chk1 positive feedback loop sustains the cellular DNA replication stress response

Niphat Jirapongwattana, Adam R. Karpf, Carley Conover, Catalina Trujillo Jaramillo
article en

Abstract

Abstract Cancer cells are continually challenged by both intrinsic and extrinsic stresses that interfere with DNA replication, causing DNA replication stress (DRS). DRS can fuel cancer progression by increasing genomic instability, but if left unregulated, it can also cause widespread DNA damage and cell death. Consequently, cancer cells are highly dependent on the ATR/Chk1 signaling pathway to regulate DRS and ensure survival. Rad9-Hus1-Rad1 interacting nuclear orphan 1 (RHNO1) is a novel component of the ATR/Chk1 pathway and is often overexpressed in cancer cells with high DRS, where it contributes to chemotherapy resistance. However, the precise function of RHNO1 in the DRS response is still largely unknown. Here, we investigated the roles of RHNO1 in cancer progression and DRS response using an ovarian cancer cell (OVC) model in both in vitro and in vivo systems. Furthermore, we generated an endogenously HiBiT-tagged and degron-tagged RHNO1 cell line to precisely track RHNO1 levels and temporally deplete RHNO1 during different phases of the DRS response in HEK293T cells. Depletion of RHNO1 significantly reduces OVC proliferation rate, clonogenicity, and in vivo tumor growth, while extending host mouse survival. RHNO1 knockdown sensitized cells to hydroxyurea (HU), increasing cell death and micronuclei formation. Mechanistically, RHNO1 was upregulated and stabilized following DRS. Notably, we show that RHNO1 stabilization is mediated by ATR/Chk1 phosphorylation, which is also required for RHNO1 translocation to stressed replication forks. Interestingly, chromatin recruitment of RHNO1 appears to be independent of 9-1-1, a DNA clamp complex previously known to bind RHNO1. Furthermore, cells with stable RHNO1 knockdown demonstrated normal initial ATR/Chk1 signaling activation in response to HU treatment, however, at later time points, the absence of RHNO1 caused premature termination of ATR/Chk1 signaling despite the persistence of DRS. These findings are consistent with a dispensable role of RHNO1 in the initial activation of the ATR/Chk1 pathway but a key role in sustaining the ATR/Chk1 response. In summary, we demonstrated the RHNO1 promote critical OVC phenotypes and uncovered a novel positive feedback loop between RHNO1 and ATR/Chk1 signaling. This work identifies RHNO1 as a key component in maintaining the DRS response, highlighting its potential as a therapeutic target for cancers reliant on ATR/Chk1 signaling. Citation Format: Niphat Jirapongwattana, Carley M. Conover, Catalina Trujillo Jaramillo, Adam R. Karpf. A RHNO1-ATR/Chk1 positive feedback loop sustains the cellular DNA replication stress response [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 4684.

Cancer ResearchVol. 86(7_Supplement)
University of Nebraska Medical Center (US)
Openalex Percentile: Top 7%
DNA Repair Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.